4.5 Article

Case report: simultaneous occurrence of multiple myeloma and non-Hodgkin lymphoma treated by CAR T therapy

Journal

MEDICINE
Volume 99, Issue 16, Pages -

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MD.0000000000019739

Keywords

B cell lymphoma; B cell maturation antigen; chimeric antigen receptor T; CD19; multiple myeloma

Funding

  1. National Science Foundation of China [81670150, 81800160]

Ask authors/readers for more resources

Rationale: B cell lymphoma can co-occur with multiple myeloma (MM), and the prognosis in this case is usually poor. We propose the combination of CD19-chimeric antigen receptor (CAR) T cells and BCMA-CAR T cells for the treatment of such patients to obtain a superior prognosis. Patient concerns: We present a 50-year-old patient with previous B cell lymphoma and subsequent multiple myeloma (MM). Diagnosis: A diagnosis of B cell lymphoma and MM was made. Interventions: The patient was treated with a combination of haploidentical CD19-chimeric antigen receptor (CAR) T cells and BCMA-CAR T cells. Outcomes: After CAR T cell therapy, the monoclonal plasma cells in the bone marrow and M protein disappeared. Lessons: The combination therapy of CD19- and BCMA-CAR T cells is an effective measure to treat patients with concomitant or borderline cases of B cell lymphoma and MM.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available